🔎 Trials Near Me

Utama › Pankreatitis Kronik › Pennsylvania

Kajian klinikal Pankreatitis Kronik di Pennsylvania

6 kajian untuk Pankreatitis Kronik sedang mencari peserta di lokasi di Pennsylvania.

Bandar di Pennsylvania

Teks kajian rasmi (Bahasa Inggeris)

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Mengambil pesertaKajian pemerhatian
Sehingga umur 17 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06651580

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

  • University of Pittsburgh Medical Center, Pittsburgh
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07418593

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

  • University of Pittsburgh Medical Center, Pittsburgh
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT03434392

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis

  • University of Pittsburgh Medical Center, Pittsburgh
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04996628

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

  • University of Pittsburgh Medical Center, Pittsburgh
Mengambil pesertaFasa awal 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT05771675

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus

  • University of Pittsburgh, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06729996

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.